Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Milan
Clinical trial register · Italy

Clinical Trials in Milan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 71 Brescia 3 Brindisi 3 Bari 2 Bologna 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS San Raffaele160 AstraZeneca138 Merck Sharp & Dohme LLC98 Hoffmann-La Roche81 Novartis Pharmaceuticals73 Clear sponsor filter
Site location
Milan71 Brescia3 Brindisi3 Bari2 Bologna2
All 31 locations
Target enrolment
to

Trials with a site in Milan

71 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers
NCT07815873Non Small Cell Lung Cancer, Melanoma (Skin Cancer), Endometrial Cancer, Cervical Cancer
DrugSample collection
European Institute of Oncology
Not applicable
360
Milan
2026-10-01
Recruiting
Disparities in Mental Health Screening and Support
NCT07691281Mental Health, Cancer
European Institute of Oncology
Observational
2,000
Milan
2026-09-01
Not yet open
Neurocognitive Integrity After Proton Therapy for Brain Tumor
NCT07836478Central Nervous System Tumour
European Institute of Oncology
Observational
60
Milan
2026-09
Recruiting
MELanoma Brain Metastasis Treated With CYberknife
NCT07691255Melanoma (Skin Cancer)
European Institute of Oncology
Observational
50
Milan
2026-08-25
Recruiting
Endoscopic Video-Assisted Nipple-Sparing Mastectomy
NCT07579117Endoscopic Video-assisted Nipple-sparing Mastectomy, Breast Surgery, Breast Cancer
European Institute of Oncology
Not applicable
10
Milan
2026-05-23
Recruiting
European Institute of Oncology
Phase 2
26
Milan
2026-05-11
Recruiting
European Institute of Oncology
Observational
175
Milan
2026-05-06
Not yet open
Cognitive Impairment Assessment in Breast Cancer Survivors
NCT07582770Cancer Related Cognitive Impairment, Breast Cancer Survivors
European Institute of Oncology
Observational
200
Milan
2026-05
Recruiting
DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER
NCT07690540Endometrial Cancer, Immune Checkpoint Inhibitors
European Institute of Oncology
Not applicable
510
Milan
2026-04-14
Recruiting
European Institute of Oncology
Not applicable
150
Milan
2026-03-26
Recruiting
European Institute of Oncology
Observational
50
Milan
2026-02-02
Recruiting
Germline Genetic Testing of the TP53 Gene
NCT07419893TP53 Gene Mutation, Multi-Gene Transcriptional Profiling, TP53 Gene Germline Mutation Carrier
European Institute of Oncology
Observational
1,940
Milan
2026-01-29
Recruiting
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
NCT07278726ALND, Sentinel Lymph Node Biopsy (SLNB), Targeted Axillary Dissection (TAD)
European Institute of Oncology
Observational
150
Bologna, Forlì, Milan, Naples, Ortona, Pavia, Pisa, Roma
2026-01-28
Not yet open
European Institute of Oncology
Not applicable
20
Milan
2026-01-22
Recruiting
Sexual Well-being of Women Undergoing Mastectomy and Reconstruction
NCT07234461Mastectomy and Breast Reconstruction, Sexual Wellness
European Institute of Oncology
Not applicable
200
Bari, Bologna, Cesena, Forlì, Milan, Olbia, Padova, Palermo
2026-01-21
Not yet open
IMMUNOTHERAPY EFFICACY TARGETING ENDOMETRIAL CANCER
NCT07374809Endometrial Carcinoma (EC), pMMR, DMMR Cancer
European Institute of Oncology
Not applicable
50
Milan
2026-01-21
Recruiting
CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors
NCT07429851Neuroendocrine Carcinoma of Lung, Neuroendocrine Carcinoma of Thymus
European Institute of Oncology
Observational
34
Milan
2026-01-01
Recruiting
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864NSCLC, Lung Cancer (Diagnosis)
European Institute of Oncology
Observational
25
Milan
2025-12-18
Recruiting
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC
NCT07080944Invasive Breast Carcinoma, Sentinel Lymph Node Biopsy (SLNB), Neoadjuvant Chemotherapy
European Institute of Oncology
Not applicable
75
Milan
2025-12-12
Recruiting
European Institute of Oncology
Observational
3
Milan
2025-11-19
Recruiting
European Institute of Oncology
Observational
750
Bergamo, Brescia, Brindisi, Crema, Lecco, Legnano, Milan, Modena
2025-09-29
Recruiting
European Institute of Oncology
Observational
84
Milan
2025-07-31
Recruiting
Personalization of External Beam Radiation Therapy in Localised Tumours
NCT07047495Breast Adenocarcinoma, Prostate Cancer (Adenocarcinoma)
European Institute of Oncology
Observational
35
Milan
2025-07
Recruiting
Real-WorlD ZolbetUximab in Patients With HER-2 Negative and CLaudin 18.2 PosItive MetastatiC AdEnocarcinoma
NCT07427992Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
European Institute of Oncology
Observational
70
Milan
2025-06-20
Recruiting
Digital Solutions for bEtter cAre
NCT07416513Cancer Diagnosis
European Institute of Oncology
Not applicable
200
Milan
2025-05-14
Active, closed
European Institute of Oncology
Not applicable
100
Milan
2025-04-08
Not yet open
Robotic Nipple Sparing Mastectomy with Immediate Reconstruction
NCT06860217Breast Cancer, DCIS, BRCA Mutation
European Institute of Oncology
Not applicable
24
Milan
2025-04
Recruiting
European Institute of Oncology
Phase 2
45
Monza, Roma, Brindisi, Milan
2025-03-06
Not yet open
European Institute of Oncology
Not applicable
190
Milan
2025-02
Recruiting
A New Tool to Promote Patient's Engagement in Their Healthcare Process
NCT06762496Breast Carcinoma, Breast Cancer Stage I, Breast Cancer Stage II
European Institute of Oncology
Observational
180
Milan
2025-01-22
Recruiting
Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance
NCT06773650Lactose Intolerant, Lactose Malabsorption, Lactose Intolerance
European Institute of Oncology
Observational
385
Milan
2025-01-08
Recruiting
European Institute of Oncology
Observational
125
Milan
2024-12-20
Recruiting
European Institute of Oncology
Observational
80
Milan
2024-12-20
Not yet open
European Institute of Oncology
Phase 3
95
Milan
2024-12-01
Recruiting
PIK3CA Mutational Status Assessment
NCT06706570Breast Cancer Metastatic
European Institute of Oncology
Observational
100
Milan
2024-11-06
Recruiting
Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
NCT06790264Breast Cancer Invasive, Node Positive Breast Cancer
European Institute of Oncology
Not applicable
92
Milan
2024-11-01
Not yet open
High Definition Profiling of Ovarian Cancer Ascites
NCT06553742Ovarian Cancer, High Grade Ovarian Serous Adenocarcinoma, Ascites
European Institute of Oncology
Observational
50
Milan
2024-11
Recruiting
European Institute of Oncology
Observational
60
Milan
2024-10-24
Recruiting
EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms
NCT06785597Mixed Neuroendocrine-Non Neuroendocrine Neoplasm, Neuroendocrine Neoplasm
European Institute of Oncology
Observational
130
Milan
2024-10-21
Recruiting
European Institute of Oncology
Not applicable
82
Milan
2024-09-06
Recruiting
European Institute of Oncology
Not applicable
60
Milan
2024-09-01
Recruiting
Evaluation of the PreCursor-M+® in CIN2
NCT06403618Cervical Intraepithelial Neoplasia Grade 2
European Institute of Oncology
Observational
100
Milan
2024-06-17
Not yet open
European Institute of Oncology
Not applicable
120
Milan
2024-06-15
Recruiting
European Institute of Oncology
Observational
234
Milan
2024-04-15
Recruiting
Psychological Assessment in Patients Treated with Spinal Cord Stimulation
NCT06761300Spinal Cord Stimulation (SCS), Chronic Pain
European Institute of Oncology
Observational
50
Milan
2024-04-09
Recruiting
European Institute of Oncology
Observational
60
Milan
2024-03-06
Recruiting
European Institute of Oncology
Observational
104
Milan
2024-01-25
Recruiting
European Institute of Oncology
Observational
30
Milan
2024-01-11
Recruiting
Cognitive Screening in Lung Cancer Patients
NCT06727370Lung Disease, NSCLC (Non-small Cell Lung Cancer), SCLC
European Institute of Oncology
Observational
200
Milan
2024-01-10
Recruiting
Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
NCT06281210Breast Cancer, Triple Negative Breast Cancer, HER2-positive Breast Cancer, Neoadjuvant Chemotherapy
European Institute of Oncology
Not applicable
77
Candiolo, Milan
2023-12-11
Recruiting
European Institute of Oncology
Observational
270
Milan
2023-09-11
Recruiting
European Institute of Oncology
Observational
2,000
Milan
2023-04-14
Recruiting
YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.
NCT06337760Neuroendocrine Neoplasm, Adenocarcinoma
European Institute of Oncology
Observational
90
Milan
2023-03-10
Recruiting
European Institute of Oncology
Not applicable
60
Milan
2023-02-20
Recruiting
Minimally Invasive Treatments of the Thyroid
NCT06333587Papillary Thyroid Microcarcinoma
European Institute of Oncology
Observational
270
Milan
2022-10-10
Recruiting
European Institute of Oncology
Observational
320
Milan
2022-07-21
Recruiting
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
NCT06327568Anal Intraepithelial Neoplasia 2, Anal Intraepithelial Neoplasia 1, Anal Cancer, High-Risk Cancer
European Institute of Oncology
Observational
200
Milan
2022-06-17
Active, closed
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients
NCT05410951Lobular Breast Carcinoma, Lobular in Situ Breast Carcinoma, BRCA1 Mutation, BRCA2 Mutation
European Institute of Oncology
Observational
800
Milan
2022-05-16
Recruiting
European Institute of Oncology
Observational
3
Milan
2022-03-15
Recruiting
European Institute of Oncology
Phase 2
46
Milan
2022-01-14
Recruiting
European Institute of Oncology
Not applicable
318
Milan
2022-01-01
Recruiting
European Institute of Oncology
Not applicable
79
Milan
2021-07-31
Recruiting
European Institute of Oncology
Not applicable
18
Milan
2021-04-23
Recruiting
Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors
NCT06785077Leukemia, Myeloid, Acute, Myeloid Dysplasia, Ovarian Epithelial Cancer
European Institute of Oncology
Not applicable
157
Milan
2020-10-02
Recruiting
European Institute of Oncology
Observational
40
Milan
2020-07-03
Recruiting
European Institute of Oncology
Phase 2
46
Milan
2020-05-20
Recruiting
fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases
NCT06328465Invasive Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer
European Institute of Oncology
Not applicable
145
Milan
2019-11-22
Recruiting
European Institute of Oncology
Observational
120
Milan
2019-04-18
Active, closed
NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma
NCT06972693Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma
European Institute of Oncology
Phase 4
323
Milan
2018-06-12
Recruiting
Radiotherapy Treatments for Neoplasms of the Limbs
NCT06335251Bone Neoplasms, Bone Metastases
European Institute of Oncology
Observational
3,000
Milan
2018-02-22
Active, closed
Sentinel Node Vs Observation After Axillary Ultra-souND
NCT02167490Early Stage Breast Carcinoma
European Institute of Oncology
Not applicable
1,560
Bolzano, Brescia, Cagliari, Castellanza, Como, Mantua, Milan, Naples
2012-01
Rows per page Showing 1–71 of 71
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/milan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 71 of those studies with a site in Milan that also match the filters currently applied.

How many clinical trials are recruiting in Milan?

57 of the 71 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 10 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Milan), 71 studies
PhaseStudiesRecruitingShare
Observational413757.7%
Not applicable241633.8%
Phase 2445.6%
Phase 3101.4%
Phase 4101.4%

Most active sponsors

Lead sponsors with the most studies (Milan)
Lead sponsorStudiesRecruiting
European Institute of Oncology7157
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.